Rama Rao Amara spends much of his time researching Virology, Immunology, Virus, Immune system and Simian immunodeficiency virus. His Virology research incorporates themes from Cellular immunity, Cytokine and Modified vaccinia Ankara. His Modified vaccinia Ankara research is multidisciplinary, relying on both Orthopoxvirus and Avidity.
His research links Cytotoxic T cell with Immunology. His Virus study combines topics in areas such as T lymphocyte, Vaccinia, Poxviridae, Recombinant DNA and Epitope. Rama Rao Amara interconnects Apoptosis, Blockade, AIDS Vaccines, Mucous membrane and Antibody in the investigation of issues within Immune system.
Rama Rao Amara focuses on Virology, Immunology, Immune system, Virus and Simian immunodeficiency virus. His study in Virology is interdisciplinary in nature, drawing from both Vaccinia, Modified vaccinia Ankara, Cytotoxic T cell and Antibody. In his research, Antibody titer is intimately related to T cell, which falls under the overarching field of Cytotoxic T cell.
In the field of Immune system, his study on Acquired immune system overlaps with subjects such as Pilus. His Virus research includes elements of DNA, Recombinant virus, Recombinant DNA and Orthopoxvirus. His work on SAIDS Vaccines as part of general Simian immunodeficiency virus study is frequently linked to Macaque, bridging the gap between disciplines.
Rama Rao Amara mainly investigates Virology, Antibody, Vaccination, Immunology and Modified vaccinia Ankara. His Virology study combines topics from a wide range of disciplines, such as Cytotoxic T cell, HIV vaccine and Gp41. In his research on the topic of Antibody, Antibody titer, Cellular immunity and Viral vector is strongly related with T cell.
The various areas that Rama Rao Amara examines in his Vaccination study include Adjuvant, B cell and Immunity. As part of his studies on Modified vaccinia Ankara, Rama Rao Amara often connects relevant subjects like Simian immunodeficiency virus. The Simian immunodeficiency virus study combines topics in areas such as Breastfeeding, Priming and DNA.
His scientific interests lie mostly in Antibody, Vaccination, Immunity, Virology and Modified vaccinia Ankara. His Antibody study is associated with Immunology. His research on Virology often connects related topics like Cytotoxic T cell.
His Cytotoxic T cell study incorporates themes from Acquired immune system, Priming and Simian immunodeficiency virus. His Modified vaccinia Ankara research is multidisciplinary, incorporating perspectives in Oral mucosa and Buccal administration. His HIV vaccine study which covers Neutralizing antibody that intersects with Vaccinia, Neutralization, Cellular immunity and Viral vector.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.
Rama Rao Amara;Francois Villinger;John D. Altman;Shari L. Lydy.
Science (2001)
Enhancing SIV-specific immunity in vivo by PD-1 blockade
Vijayakumar Velu;Kehmia Titanji;Kehmia Titanji;Baogong Zhu;Sajid Husain;Sajid Husain.
Nature (2009)
Broadly cross-reactive antibodies dominate the human B cell response against 2009 pandemic H1N1 influenza virus infection
Jens Wrammert;Dimitrios G. Koutsonanos;Gui-Mei Li;Srilatha Edupuganti.
Journal of Experimental Medicine (2011)
Multiple-Cytokine-Producing Antiviral CD4 T Cells Are Functionally Superior to Single-Cytokine-Producing Cells
Sunil Kannanganat;Chris Ibegbu;Lakshmi Chennareddi;Harriet L. Robinson.
Journal of Virology (2007)
T cell vaccines for microbial infections
Harriet L Robinson;Rama Rao Amara.
Nature Medicine (2005)
Critical Role for Env as well as Gag-Pol in Control of a Simian-Human Immunodeficiency Virus 89.6P Challenge by a DNA Prime/Recombinant Modified Vaccinia Virus Ankara Vaccine
Rama Rao Amara;James M. Smith;James M. Smith;Silvija I. Staprans;David C. Montefiori.
Journal of Virology (2002)
Different Patterns of Immune Responses but Similar Control of a Simian-Human Immunodeficiency Virus 89.6P Mucosal Challenge by Modified Vaccinia Virus Ankara (MVA) and DNA/MVA Vaccines
Rama Rao Amara;Francois Villinger;Silvija I. Staprans;Silvija I. Staprans;John D. Altman.
Journal of Virology (2002)
PD-1 blockade during chronic SIV infection reduces hyperimmune activation and microbial translocation in rhesus macaques
Ravi Dyavar Shetty;Vijayakumar Velu;Kehmia Titanji;Steven E. Bosinger.
Journal of Clinical Investigation (2012)
Human Immunodeficiency Virus Type 1 Controllers but Not Noncontrollers Maintain CD4 T Cells Coexpressing Three Cytokines
Sunil Kannanganat;Bill G. Kapogiannis;Bill G. Kapogiannis;Chris Ibegbu;Lakshmi Chennareddi.
Journal of Virology (2007)
Elevated Expression Levels of Inhibitory Receptor Programmed Death 1 on Simian Immunodeficiency Virus-Specific CD8 T Cells during Chronic Infection but Not after Vaccination
Vijayakumar Velu;Sunil Kannanganat;Chris Ibegbu;Lakshmi Chennareddi.
Journal of Virology (2007)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Emory University
Duke University
National Institutes of Health
University of Louisiana at Lafayette
National Institutes of Health
National Institute of Allergy and Infectious Diseases
Emory University
Harvard University
Emory University
Emory University
École des Ponts ParisTech
Duke University
Wuhan University
University of Strasbourg
University of Geneva
University of Lübeck
Seoul National University of Science and Technology
University of Oxford
Israel Oceanographic and Limnological Research
University of Tasmania
Wageningen University & Research
University of Tokyo
Boston University
Sorbonne University
Hyogo College of Medicine
Sapienza University of Rome